MustGrow Biologics upsizes non-brokered private placement to $3.7 million at $0.5 per unit

VanEck Morningstar Wide Moat Growth ETF

VanEck Morningstar Wide Moat Growth ETF

MGRO

0.00
  • MustGrow raised its non-brokered listed issuer financing exemption private placement to about $3.7 million on stronger investor demand.
  • Closing is set for June 18, 2026, with about 7,400,000 units priced at $0.5 each.
  • Each unit includes one common share, one 60-month warrant exercisable at $0.7 per share.
  • Proceeds earmarked for TerraSante inventory production, working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MustGrow Biologics Corp. published the original content used to generate this news brief on June 17, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.